As IS Portfolio Manager with over 15 years of experience in life sciences, I am leading digital transformation across Global Quality & Compliance, Manufacturing, and Clinical & Regulatory domains at bioMérieux. I specialize in bridging business, IT, and scientific environments, driving complex programs such as LIMS transformations and data platforms in highly regulated contexts. Today, I focus on portfolio governance, strategic alignment, and value-driven investment decisions, ensuring the delivery of scalable solutions that enhance data governance, operational efficiency, and business performance.
Drive portfolio governance and prioritization by evaluating project requests, defining scope, arbitrating priorities and budget allocation depending on the business value
Lead budget (~3M€) planning and performance tracking, co-building financial forecasts and ensuring alignment between business needs and IS investment strategy
Act as a key interface between IS and business stakeholders to align on needs, validate solutions, and ensure delivery consistency with organizational strategy
Oversee end-to-end portfolio delivery, including scoping, roadmap definition, backlog management, and monitoring execution of multiple concurrent projects
Ensure compliance and quality alignment of IS initiatives, supporting regulatory requirements (e.g., GxP, ISO standards) and enabling robust, auditable processes and systems
Led end-to-end delivery of large-scale LIMS transformation programs, managing upgrade, integration and multi-site rollouts, validation cycles, and go-live readiness for QC laboratories across international locations
Drove business–IT alignment, translating complex QC & R&D needs into functional specifications (URS/FRS), impact assessments, and test strategies, ensuring regulatory-compliant system design
Played a key role in strategic digital initiatives (SPOT & MDM R&D), contributing to the implementation of “single source of truth” solutions to centralize product data and structure R&D knowledge bases
Delivered measurable operational improvements, optimizing laboratory workflows, automating processes, and enhancing system performance, scalability, and user adoption in regulated environments
Led multiple R&D and QC IT initiatives as IS Project Manager & Business Analyst, driving tool upgrades, feasibility studies, and developments to support new diagnostic assay development and laboratory optimization (Nephrocheck, Tempo Evo, ELN)
Delivered Process standardization solutions, including SampleBank deployment across international R&D sites and enhancements to global labeling tools for QC/QP activities (CABMLE / GLT)
Strengthened traceability, data quality, and operational efficiency across R&D and QC environments
Led and coordinated innovative R&D research projects on invasive pulmonary aspergillosis, contributing to both diagnostic strategies (real-time PCR assay optimization) and therapeutic approaches (antifungal mode of action and target identification)
Drove scientific impact and team development, mentoring laboratory technicians and publishing results (12 peer-reviewed articles + 1 book chapter), strengthening knowledge dissemination in infectious diseases
Led and developed an R&D project in plant pathology, focusing on the identification of novel antifungal targets in Magnaporthe grisea (rice blast fungus), contributing to crop protection innovation
Managed scientific deliverables and funding activities, including grant and final report to stakeholders
Strengthened team and laboratory practices, mentoring undergraduate students and ensuring compliance with BPL and HSQE standards through regular internal audits
